Get Adobe Flash player
News & Events

Ratification of illicit trade pact nears halfway mark

Ratification of the World Health Organisation’...

PMI says Australian volume stable despite plain packs

Cigarette volume in Australia has remained sta...

Greeks turn to contraband

Fewer than 20 billion cigarettes were consumed ...

UK Filtrona rebrands to Essentra

Filtrona plc will rebrand to Essentra plc from...

EU Study criticises impact statement for revised TPD

The Regulatory Impact Assessment (RIA) of prop...

Ireland government backs plain packaging

Ireland plans to become the second country aft...

Central EU countries criticise TPD

Six central and eastern European countries in ...

United States, Universal core tobacco sales flat

Universal Corp flue-cured/burley leaf sales an...

Zimbabwe low early burley auction prices

More than 55,000 kg of burley tobacco auctione...

World Tobacco leaf conference in Istanbul

A conference on leaf issues with experts from ...

NYC tobacco product display ban proposed

New York City Mayor Michael Bloomberg said his...

USA government shelves warning label appeal

The federal government will not pursue its leg...

Malawi Tobacco volume may double in 2013

Tobacco volume this year is expected to reach ...

Major smuggling ring before Berlin court

A gang member arrested at one of the largest i...

PMI’s Calantzopoulos to replace Camilleri as CEO

Philip Morris International (PMI) Chief Operat...

Subscribe To Our News:
Name:
Email:
Who's Online:
We have 44 guests online
Content View Hits : 186513

Second-hand Smoke

The World Health Organization, the United States Surgeon General and other public health bodies have concluded that exposure to environmental tobacco smoke (ETS), sometimes called ‘second-hand smoke’, is a cause of various serious diseases, including lung cancer, heart disease and respiratory illnesses in children.

They conclude that there is no known safe level of ETS exposure and hence advise that public health policy would be best served by bans on public smoking.


Our view of the science:

The risks associated with ETS have been measured in epidemiological studies. These mainly use questionnaires to compare the incidence of diseases such as lung cancer in non-smoking women whose husbands were smokers, with non-smoking women whose husbands were non-smokers.

For lung cancer, the major studies report that relative risk associated with prolonged non-smoker exposure to ETS is 1.3. A relative risk of 1 means no risk, and prolonged active smoking is typically associated with a relative risk of lung cancer of the order of 20 or higher.

For heart disease, the major studies also report a relative risk for ETS exposure of around 1.3. The relative risk for active smoking and heart disease is typically of the order of 3 to 5.

Many epidemiologists say that relative risks below 2 are weak associations and are more difficult to quantify than stronger associations. Perhaps because the relative risks reported in individual studies tend to be below 2, many studies do not reach statistical significance.

Studies of respiratory illnesses in children whose parents smoke, and research into whether ETS exposure exacerbates symptoms for people with conditions such as asthma, suggest that ETS can increase risks of respiratory illnesses in children and can affect people with pre-existing conditions such as asthma.


Our approach to regulation:

We support regulation that accommodates the interests of both non-smokers and smokers and limits non-smokers’ involuntary exposure to ETS.

We favour restrictions on smoking in enclosed public places and we accept that there needs to be regulation. We support practical initiatives such as the creation of smoke-free areas, combined with adequate provision for smokers.